https://bio.nikkeibp.co.jp/atcl/news/p1/23/02/13/10395/
The plant-based veterinary drug Interberry Alpha has gained an indication for the treatment of feline gingivitis in addition to the existing indication for canine gingivitis. Information on the expanded indication was made public on February 13, 2023 in the database of the Veterinary Drug Inspectorate of the Ministry of Agriculture, Forestry and Fisheries of Japan.
Interberry Alpha is a canine interferon gene introduced into strawberries and a lyophilized powder applied to the gums; it was approved as a canine gingivitis drug in 2013. It was jointly developed by Hokusan (Kitahiroshima City, Hokkaido; President Kaoru Ujiie), a Hokkaido-based agrochemical manufacturer and seller, the National Institute of Advanced Industrial Science and Technology, and Kitasato Daiichi Sankyo Vaccine (now merged with Daiichi Sankyo), a member of the Daiichi Sankyo Group.